A Pilot Study of Neoadjuvant FOLFOX Plus Bevacizumab Chemotherapy in Patients With Locally Advanced Colon Cancer
Phase of Trial: Phase II
Latest Information Update: 23 Apr 2015
At a glance
- Drugs Bevacizumab (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Colon cancer
- Focus Therapeutic Use
- 02 Feb 2012 Actual initiation date changed from Jan 2009 to Feb 2009 as reported by ClinicalTrials.gov.
- 02 Feb 2012 Planned end date changed from 1 Jan 2013 to 1 Jan 2011 as reported by ClinicalTrials.gov.
- 02 Feb 2012 Status changed from completed to discontinued as reported by ClinicalTrials.gov.